midodrine has been researched along with Circulatory Collapse in 6 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Excerpt | Relevance | Reference |
---|---|---|
"To evaluate the effects of midodrine in addition to intravenous vasopressor therapy on outcomes in adults recovering from shock." | 9.05 | Midodrine as an Adjuvant to Intravenous Vasopressor Agents in Adults With Resolving Shock: Systematic Review and Meta-Analysis. ( Balk, RA; Hammond, DA; Menich, BE; Peksa, GD; Smith, MN; Trivedi, AP, 2020) |
"Midodrine has been used as an oral agent for haemodynamic support in patients with orthostatic hypotension or cirrhosis." | 5.72 | Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis. ( Bagshaw, SM; Fiest, K; Kamaleldin, M; Karvellas, CJ; Kilcommons, S; Kutsogiannis, J; Lau, V; MacIntyre, E; Opgenorth, D; Rewa, OG; Rochwerg, B; Senaratne, J; Slemko, J; Sligl, W; Wang, X, 2022) |
"To evaluate the effects of midodrine in addition to intravenous vasopressor therapy on outcomes in adults recovering from shock." | 5.05 | Midodrine as an Adjuvant to Intravenous Vasopressor Agents in Adults With Resolving Shock: Systematic Review and Meta-Analysis. ( Balk, RA; Hammond, DA; Menich, BE; Peksa, GD; Smith, MN; Trivedi, AP, 2020) |
"Treatment with midodrine and albumin was associated with a slight but significant decrease in plasma renin activity and aldosterone compared to placebo (renin -4." | 2.87 | Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial. ( Ariza, X; Castellote, J; Colmenero, J; Córdoba, J; de Prada, G; Fabrellas, N; Garcia-Martínez, R; Ginès, P; Graupera, I; Guevara, M; Huelin, P; Lopez Benaiges, E; Manríquez, M; Márquez, F; Martín-Llahí, M; Moreira, R; Navasa, M; Nazar, A; Pavesi, M; Pose, E; Simón-Talero, M; Solà, E; Solé, C; Suñé, P; Torrens, M; Vargas, V; Ventura, M; Xiol, X, 2018) |
"Midodrine has been used as an oral agent for haemodynamic support in patients with orthostatic hypotension or cirrhosis." | 1.72 | Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis. ( Bagshaw, SM; Fiest, K; Kamaleldin, M; Karvellas, CJ; Kilcommons, S; Kutsogiannis, J; Lau, V; MacIntyre, E; Opgenorth, D; Rewa, OG; Rochwerg, B; Senaratne, J; Slemko, J; Sligl, W; Wang, X, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 5 (83.33) | 2.80 |
Authors | Studies |
---|---|
Kamaleldin, M | 3 |
Kilcommons, S | 3 |
Opgenorth, D | 3 |
Fiest, K | 3 |
Karvellas, CJ | 3 |
Kutsogiannis, J | 3 |
Lau, V | 3 |
MacIntyre, E | 3 |
Rochwerg, B | 3 |
Senaratne, J | 3 |
Slemko, J | 3 |
Sligl, W | 3 |
Wang, X | 3 |
Bagshaw, SM | 3 |
Rewa, OG | 3 |
Marigliano, B | 1 |
Internullo, M | 1 |
Scuro, L | 1 |
Tavanti, A | 1 |
Del Vecchio, LR | 1 |
Schito, MB | 1 |
Colombo, GM | 1 |
Guglielmelli, E | 1 |
Khokher, W | 1 |
Iftikhar, S | 1 |
Beran, A | 1 |
Burmeister, C | 1 |
Abrahamian, A | 1 |
Abuhelwa, Z | 1 |
Malhas, SE | 1 |
Khuder, S | 1 |
Assaly, R | 1 |
Tripathy, A | 1 |
Maiti, R | 1 |
Jena, M | 1 |
Mishra, A | 1 |
Srinivasan, A | 1 |
Solà, E | 1 |
Solé, C | 1 |
Simón-Talero, M | 1 |
Martín-Llahí, M | 1 |
Castellote, J | 1 |
Garcia-Martínez, R | 1 |
Moreira, R | 1 |
Torrens, M | 1 |
Márquez, F | 1 |
Fabrellas, N | 1 |
de Prada, G | 1 |
Huelin, P | 1 |
Lopez Benaiges, E | 1 |
Ventura, M | 1 |
Manríquez, M | 1 |
Nazar, A | 1 |
Ariza, X | 1 |
Suñé, P | 1 |
Graupera, I | 1 |
Pose, E | 1 |
Colmenero, J | 1 |
Pavesi, M | 1 |
Guevara, M | 1 |
Navasa, M | 1 |
Xiol, X | 1 |
Córdoba, J | 1 |
Vargas, V | 1 |
Ginès, P | 1 |
Hammond, DA | 1 |
Smith, MN | 1 |
Peksa, GD | 1 |
Trivedi, AP | 1 |
Balk, RA | 1 |
Menich, BE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Midodrine and Albumin for Cirrhotic Patients in the Waiting List for Liver Transplantation[NCT00839358] | Phase 4 | 199 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for midodrine and Circulatory Collapse
Article | Year |
---|---|
Utility of Midodrine During the Recovery Phase of Shock: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Topics: Humans; Midodrine; Randomized Controlled Trials as Topic; Shock; Vasoconstrictor Agents | 2023 |
Effect of alpha agonists on the prevention of postparacentesis circulatory dysfunction in patients with refractory or recurrent ascites: a meta-analysis.
Topics: Aldosterone; Ascites; Humans; Midodrine; Shock | 2020 |
Midodrine as an Adjuvant to Intravenous Vasopressor Agents in Adults With Resolving Shock: Systematic Review and Meta-Analysis.
Topics: Administration, Intravenous; Adult; Humans; Intensive Care Units; Midodrine; Shock; Vasoconstrictor | 2020 |
1 trial available for midodrine and Circulatory Collapse
Article | Year |
---|---|
Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
Topics: Adult; Aged; Albumins; Aldosterone; Ascites; Double-Blind Method; Female; Follow-Up Studies; Humans; | 2018 |
2 other studies available for midodrine and Circulatory Collapse
Article | Year |
---|---|
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine therapy for vasopressor dependent shock in the intensive care unit: a protocol for a systematic review and meta-analysis.
Topics: Critical Illness; Humans; Intensive Care Units; Meta-Analysis as Topic; Midodrine; Review Literature | 2022 |
Midodrine and albumin as a possible "winning pair" in managing paracentesis-induced circulatory dysfunction: a clinical case report.
Topics: Albumins; Ascites; Diuretics; Female; Heart Failure; Humans; Liver Cirrhosis; Middle Aged; Midodrine | 2022 |